Explore By Subject Area   

Spatial Biomarker Panels for Clinical Trials

Sponsored by RareCyte

This webinar covers how recent advances in multiplex immunofluorescence technology are enabling high-throughput analysis of high-plex biomarker panels for oncology trials.

March 18, 2026, 1:00 PM
Spatial Biomarker Panels for Clinical Trials
Register Now

Registration is complimentary and required to attend.

About this webinar: 

Most immuno-oncology drugs work by altering the tumor microenvironment to recruit and activate immune cells. To understand how these drugs work and how patients respond, researchers need the spatial context of several biomarkers—typically 8 to 18—to see how cells interact within the tumor. Traditional multiplex immunofluorescence (mIF) methods can’t capture this complexity at scale. 

Through a case study and technology walk-through, this webinar highlights the barriers that have been broken in mIF that now enable flexible development of high performance high-plex biomarker panels, and application of those panels at the scale necessary for deriving valuable quantitative spatial insights from large cohort clinical trials.  

More specifically, webinar attendees will learn: 

  • How recent advances in mIF address previous hurdles, including: lack of validated reagents; limited ability to add custom biomarkers; high cost and low throughput associated with detecting more markers in large volume clinical trials 
  • How incorporation of immune response biomarkers with target biomarkers provides more comprehensive insights  
  • How CRO experts are working with pharma and using multiplex immunofluorescence to profile high-plex biomarker panels in clinical trial settings 


About RareCyte: 

RareCyte provides innovative Precision Biology™ products and services for discovery, translational, and clinical research applications. The Orion™ spatial biology platform enables whole-slide highly multiplexed tissue analysis at clinical trial scale. For more information, please visit www.rarecyte.com 

About IO360º: 

IO360˚ is an annual conference that convenes key stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.  Visit www.IO360summit.com for more information.  

About Questex:  

Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here. 


In this webinar
Register Now

Registration is complimentary and required to attend.

Sponsored by

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.